The PIPAF trials are a set of randomized multicenter studies which seeks to
evaluate the potential preventive effect of different modes of pacing in p
atients with drug refractory paroxysmal atrial fibrillation by means of a p
ermanent pacemaker. The objective of the studies are (1) to significantly p
rolong the time to first recurrence of atrial arrhythmia and (2) to signifi
cantly reduce the cumulative arrhythmia duration. The role of the atrial pa
cing site (left or right), the overdriving of the sinus rate, and the suppr
ession of the post extrasystolic compensatory pause are evaluated alone or
in association, giving rise to four distinct pacing protocols. Over a perio
d of 2 years, 220 patients will be included in 35 centers from 5 different
countries.